“She just had to put out $14,000 to completely restore and get a whole new septic system in her house because the chemo ...
TUESDAY, Dec. 24, 2024 (HealthDay News) -- When supplies of certain generic, platinum-based cancer chemotherapies dwindled in ...
The FDA approved several drugs in December for the treatment of diseases including pancreatic adenocarcinoma, lung cancer, ...
Researchers describe a new potential role for oleanic acid as a modulator of the DNA damage response following camptothecin ...
Researchers from IIT Guwahati and Bose Institute Kolkata have developed an innovative injectable hydrogel for localized ...
The approval was based on data from the randomized, placebo-controlled, double-blind, phase 3 RATIONALE-305 trial.
The antibody-drug conjugate showed a higher objective response rate but failed to meet the primary OS endpoint in patients ...
Ibudilast is under clinical development by MediciNova and currently in Phase II for Chemotherapy Induced Peripheral Neuropathy.
Capsaicin is under clinical development by Grunenthal and currently in Phase III for Chemotherapy Induced Peripheral Neuropathy.
Mutational signatures etched into the cells' genome by an anti-cancer drug called temozolomide (TMZ) uncover an Achilles' heel for TMZ chemotherapy resistance, according to new research.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback